Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-06 Option Award | 2024-06-10 4:15 pm | N/A 2034-06-05 | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 20,543 | $0 | 20,543 (Direct) | View |
| 2024-06-01 Exercise | 2024-06-04 4:30 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 4,660 | $0 | 53,163 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-22 4:32 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 16,500 | $1.41 | 48,503 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-22 4:32 pm | N/A 2030-06-03 | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 16,500 | $0 | 48,503 (Direct) | View |
| 2023-06-15 Exercise | 2023-06-20 4:31 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 51 | $0.72 | 32,003 (Direct) | View |
| 2023-06-15 Exercise | 2023-06-20 4:31 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 198 | $1.52 | 32,003 (Direct) | View |
| 2023-06-15 Exercise | 2023-06-20 4:31 pm | N/A 2024-08-12 | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 249 | $0 | 32,003 (Direct) | View |
| 2023-06-02 Exercise | 2023-06-05 5:02 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 4,507 | $0 | 52,164 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 5:02 pm | N/A 2033-05-31 | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 20,410 | $0 | 52,164 (Direct) | View |
| 2022-06-03 Exercise | 2022-06-06 5:27 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 3,356 | $0 | 47,504 (Direct) | View |
| 2022-06-02 Option Award | 2022-06-06 5:27 pm | N/A 2032-06-01 | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 20,257 | $0 | 47,504 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-04 8:05 pm | N/A 2031-06-02 | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 15,606 | $0 | 15,606 (Direct) | View |
| 2020-06-06 Exercise | 2020-06-08 5:31 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 7,333 | $0 | 40,391 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 5:31 pm | N/A 2030-06-03 | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 16,500 | $0 | 40,391 (Direct) | View |
| 2020-03-02 Exercise | 2020-03-04 4:26 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 8,876 | $0 | 25,434 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-04 4:26 pm | N/A N/A | Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director | 8,876 | $0 | 25,434 (Direct) | View |